FI116036B - Menetelmä stabiilien lyofilisoitujen tiotepakoostumuksien valmistamiseksi - Google Patents

Menetelmä stabiilien lyofilisoitujen tiotepakoostumuksien valmistamiseksi Download PDF

Info

Publication number
FI116036B
FI116036B FI945252A FI945252A FI116036B FI 116036 B FI116036 B FI 116036B FI 945252 A FI945252 A FI 945252A FI 945252 A FI945252 A FI 945252A FI 116036 B FI116036 B FI 116036B
Authority
FI
Finland
Prior art keywords
thiotepa
pharmaceutically acceptable
preparation
solution
lyophilized
Prior art date
Application number
FI945252A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI945252A0 (fi
FI945252A (fi
Inventor
Mannching S Ku
Jorge Velez
Joe Hoffman
Lourdes Zamora
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of FI945252A0 publication Critical patent/FI945252A0/fi
Publication of FI945252A publication Critical patent/FI945252A/fi
Application granted granted Critical
Publication of FI116036B publication Critical patent/FI116036B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI945252A 1993-11-09 1994-11-08 Menetelmä stabiilien lyofilisoitujen tiotepakoostumuksien valmistamiseksi FI116036B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15050193A 1993-11-09 1993-11-09
US15050193 1993-11-09

Publications (3)

Publication Number Publication Date
FI945252A0 FI945252A0 (fi) 1994-11-08
FI945252A FI945252A (fi) 1995-05-10
FI116036B true FI116036B (fi) 2005-09-15

Family

ID=22534834

Family Applications (1)

Application Number Title Priority Date Filing Date
FI945252A FI116036B (fi) 1993-11-09 1994-11-08 Menetelmä stabiilien lyofilisoitujen tiotepakoostumuksien valmistamiseksi

Country Status (29)

Country Link
US (1) US5561121A (fr)
EP (1) EP0656211B1 (fr)
JP (1) JP3726255B2 (fr)
KR (1) KR100348382B1 (fr)
CN (1) CN1111130A (fr)
AR (1) AR023045A2 (fr)
AT (1) ATE180670T1 (fr)
AU (1) AU690143B2 (fr)
CA (1) CA2135265A1 (fr)
CZ (1) CZ287052B6 (fr)
DE (1) DE69418832T2 (fr)
DK (1) DK0656211T3 (fr)
ES (1) ES2133152T3 (fr)
FI (1) FI116036B (fr)
GR (1) GR3031122T3 (fr)
HK (1) HK1011283A1 (fr)
HU (1) HU218216B (fr)
IL (1) IL111534A (fr)
NO (1) NO305274B1 (fr)
NZ (1) NZ264861A (fr)
PE (1) PE22995A1 (fr)
PH (1) PH31219A (fr)
PL (1) PL176984B1 (fr)
RU (1) RU2134112C1 (fr)
SG (1) SG63584A1 (fr)
SI (1) SI0656211T1 (fr)
SK (1) SK280840B6 (fr)
TW (1) TW344662B (fr)
ZA (1) ZA948833B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9726343D0 (en) * 1997-12-13 1998-02-11 Auffret Anthony The use of excipients to accelerate freeze-drying
AU2002302814A1 (en) * 2001-06-08 2002-12-23 Powderject Vaccines, Inc. Spray freeze-dried compositions
US8436190B2 (en) 2005-01-14 2013-05-07 Cephalon, Inc. Bendamustine pharmaceutical compositions
US8158152B2 (en) * 2005-11-18 2012-04-17 Scidose Llc Lyophilization process and products obtained thereby
AR072777A1 (es) 2008-03-26 2010-09-22 Cephalon Inc Formas solidas de clorhidrato de bendamustina
WO2010036702A1 (fr) 2008-09-25 2010-04-01 Cephalon, Inc. Formulations liquides de bendamustine
JP2012515210A (ja) 2009-01-15 2012-07-05 セファロン、インク． ベンダムスチン遊離塩基の新規の形態
CA2850513A1 (fr) * 2011-09-29 2013-04-04 Janssen Pharmaceutica Nv Procede de preparation de derives de sulfamides
CN104349417B (zh) * 2013-08-07 2017-11-21 中国科学院声学研究所 基于短生命周期的区域性水下通信网的组网方法
WO2018227112A1 (fr) 2017-06-09 2018-12-13 The Trustees Of Columbia University In The City Of New York Oligomères tat courts pour l'administration de médicaments
CN109956972A (zh) * 2017-12-22 2019-07-02 四川科瑞德凯华制药有限公司 塞替派晶型i及其制备方法和用途
CN110917146A (zh) * 2019-12-03 2020-03-27 黑龙江福和制药集团股份有限公司 一种塞替派粉针及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2670347A (en) * 1952-01-08 1954-02-23 American Cyanamid Co Thiophosphoric acid derivatives and method of preparing the same
GB845823A (en) * 1957-09-19 1960-08-24 Sumitomo Chemical Co Stabilised compositions comprising therapeutic imine derivatives and the preparation thereof
DE1951822C3 (de) * 1969-10-14 1980-12-11 Kowa Co., Ltd., Nagoya, Aichi (Japan) Pharmazeutisches Präparat zur Krebsbehandlung
DE2925009A1 (de) * 1979-06-21 1981-01-08 Basf Ag Zubereitung fuer substanzen, verfahren zu deren herstellung und deren verwendung
EP0120907A1 (fr) * 1982-10-13 1984-10-10 Aston Molecules Limited Preparations pharmaceutiques utilisees en therapie antitumorale
EP0140255B1 (fr) * 1983-10-14 1991-05-15 Sumitomo Pharmaceuticals Company, Limited Injections à libération prolongée
CH676508A5 (fr) * 1986-10-13 1991-01-31 Anawa Lab Ag
US4918199A (en) * 1988-01-21 1990-04-17 American Cyanamid Company Process for producing thiotepa
US5122367A (en) * 1989-03-31 1992-06-16 Massachusetts Institute Of Technology Polyanhydride bioerodible controlled release implants for administration of stabilized growth hormone
EP0419890A3 (en) * 1989-09-29 1991-05-29 American Cyanamid Company Stable pharmaceutical formulations for antineoplastic compounds having more than one ethyleneimine group, and method

Also Published As

Publication number Publication date
JP3726255B2 (ja) 2005-12-14
KR100348382B1 (ko) 2002-11-23
CA2135265A1 (fr) 1995-05-10
CZ287052B6 (en) 2000-08-16
JPH07196517A (ja) 1995-08-01
PH31219A (en) 1998-05-05
EP0656211B1 (fr) 1999-06-02
PE22995A1 (es) 1995-09-08
NO944256D0 (no) 1994-11-08
SK280840B6 (sk) 2000-08-14
DK0656211T3 (da) 1999-11-15
DE69418832D1 (de) 1999-07-08
IL111534A0 (en) 1995-01-24
RU94040150A (ru) 1996-09-20
TW344662B (en) 1998-11-11
CN1111130A (zh) 1995-11-08
PL176984B1 (pl) 1999-08-31
HUT70762A (en) 1995-10-30
FI945252A0 (fi) 1994-11-08
SK135294A3 (en) 1996-01-10
SG63584A1 (en) 1999-03-30
CZ271894A3 (en) 1995-07-12
IL111534A (en) 1999-06-20
FI945252A (fi) 1995-05-10
ATE180670T1 (de) 1999-06-15
AR023045A2 (es) 2002-09-04
AU7768994A (en) 1995-05-18
GR3031122T3 (en) 1999-12-31
PL305752A1 (en) 1995-05-15
SI0656211T1 (en) 1999-08-31
NO305274B1 (no) 1999-05-03
AU690143B2 (en) 1998-04-23
RU2134112C1 (ru) 1999-08-10
NZ264861A (en) 1995-10-26
HK1011283A1 (en) 1999-07-09
ES2133152T3 (es) 1999-09-01
EP0656211A1 (fr) 1995-06-07
ZA948833B (en) 1995-07-14
US5561121A (en) 1996-10-01
HU218216B (hu) 2000-06-28
NO944256L (no) 1995-05-10
DE69418832T2 (de) 1999-09-23
HU9403210D0 (en) 1995-01-30

Similar Documents

Publication Publication Date Title
FI116036B (fi) Menetelmä stabiilien lyofilisoitujen tiotepakoostumuksien valmistamiseksi
EP2062582B1 (fr) Compositions antibiotiques comprenant des bêtalactamines, des aminoglycosides et des tampons
KR100247161B1 (ko) 동결건조 이포스파미드 조성물
FI90204B (fi) Menetelmä injektoitavan melfalaanikoostumuksen valmistamiseksi
CA3040018A1 (fr) Formulation pharmaceutique parenterale contenant de l'acide carglumique
FI83476B (fi) Foerfarande foer framstaellning av en beredning av 7 -difluorometyltioacetamido-7 -metoxi-3-/1-(2 -hydroxialkyl)-1h-tetrazol-5-yl/tiometyl-1-detia-1-oxa-3-cefem-4 -karboxisyra.
US20160256557A1 (en) Injectable pharmaceutical compositions of an anthracenedione derivative with anti-tumoral activity
PL190493B1 (pl) Kompozycja farmaceutyczna do liofilizacji i jej zastosowanie oraz sposób jej wytwarzania
US8481781B2 (en) Formulations of canfosfamide and their preparation
JP4886517B2 (ja) 新たな用途の薬学的調製物およびその調製物を製造するためのプロセス
SU1213973A3 (ru) Способ стабилизации антибактериальной щелочнометаллической соли 7В-(а-карбокси-а-арилацетамидо)-7 @ -метоксил-3-гетероциклотиометил-1-детиа-1-окса-3-цефем-4-карбоновой кислоты
CS208088B1 (cs) Suchá stabilizovaná kompozice (2-amino-6-hydroxy-5-(4-karboxybutyl)-3,4- dihydro-4-oxo)pyrimidinu

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 116036

Country of ref document: FI

MA Patent expired